Landmark Wealth Management (New York)’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$626K Buy
+1,780
New +$635K 0.17% 95
2022
Q2
Sell
-275
Closed -$275 46
2022
Q1
$275 Buy
+275
New +$63.2K ﹤0.01% 159

Other funds holding AMGN

Landmark Wealth Management (New York)'s AMGN Position: Q1 2026 in Review

Landmark Wealth Management (New York) opened a new position in Amgen (AMGN) in Q1 2026: 1,780 shares worth $626K. The stake represents 0.17% of the portfolio and ranks #95 among its holdings. This is a return to the name: Landmark Wealth Management (New York) previously reported a position in AMGN as recently as Q1 2022.

Landmark Wealth Management (New York) first reported a position in AMGN in Q1 2022 and has held it in 2 quarters since. 3,132 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Landmark Wealth Management (New York) held 1,780 shares of Amgen worth $626K as of Q1 2026.
  • Amgen was a new Landmark Wealth Management (New York) position in Q1 2026.
  • Amgen made up 0.17% of Landmark Wealth Management (New York)'s portfolio in Q1 2026, its #95 holding.
  • Landmark Wealth Management (New York) first reported a position in Amgen in Q1 2022 and has held it in 2 quarters since.
  • 3,132 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Landmark Wealth Management (New York)'s 13F filing for Q1 2026, filed 29 Apr 2026.